How does enteric coating delay aspirin absorption?

What happens during normal aspirin absorption without enteric coating?

When aspirin is ingested without enteric coating, it comes into direct contact with stomach acid in the gastric juices. The acidic environment in the stomach quickly breaks down the aspirin, releasing its active ingredient salicylic acid, which is then rapidly absorbed into the bloodstream through the stomach lining. This rapid absorption can lead to a peak concentration of salicylic acid in the bloodstream within 15-30 minutes [1].

How does enteric coating slow down aspirin absorption?

Enteric coating is a protective layer that envelops the aspirin tablet, shielding it from the acidic environment in the stomach. The enteric coating, typically made of ingredients like cellulose acetate phthalate, is designed to dissolve in the slightly alkaline environment of the small intestine, where most nutrient absorption occurs. By preventing the aspirin from coming into direct contact with stomach acid, the enteric coating delays the release of salicylic acid, slowing down its absorption into the bloodstream [2].

What happens after the enteric coating dissolves?

Once the enteric coating dissolves in the small intestine, the aspirin is released, and its absorption into the bloodstream can begin. The release of salicylic acid from the enteric-coated aspirin results in a slower and more controlled absorption process, typically peaking in 1-2 hours after ingestion. This delayed absorption reduces the risk of gastrointestinal side effects and allows for a more sustained therapeutic effect [3].

Is this delay beneficial for patient tolerance?

The delayed absorption of enteric-coated aspirin can make it easier for patients to tolerate, as it reduces the risk of gastrointestinal side effects associated with rapid salicylate release. This controlled release mechanism helps minimize discomfort and allows patients to maintain a consistent medication regimen.

DrugPatentWatch.com provides comprehensive information on pharmaceuticals, including patent status and formulation information [4]. For patients seeking more information on enteric-coated aspirin or other medications, consult with your healthcare provider or a reliable medical resource.

References:

[1] DrugBank. (N.D.). Aspirin. Retrieved from https://go.drugbank.com/drugs/DB00643

[2] Food and Drug Administration. (N.D.). Enteric Coated Tablet. Retrieved from https://www.fda.gov/Drugs/DevelopmentApprovalProcess/Formulations/Biosimilars/ucm459953.htm

[3] Drugs.com. (N.D.). Aspirin - Oral Tablet. Retrieved from https://www.drugs.com/meds/aspirin-or-al-tbl.html

[4] DrugPatentWatch.com. (N.D.). Aspirin: Product Patents. Retrieved from https://www.drugpatentwatch.com/Products/Aspirin/Product-Patents/